On #WorldObesityDay, we invite you to explore the #JCLSpecialEdition on obesity, which brings together multidisciplinary insights for clinicians, researchers, educators, and public health leaders.
Read the issue: lipidjournal.com/issue/S1933-2874(26)X0002-2
#JCLSpecialEdition #Obesity
Diagnosis and management of CVD risk factors is an important aspect of an obesity management plan.
Evidence shows treatment with liraglutide, semaglutide, and/or bariatric surgery lowers CVD events and mortality.
Explore the full findings: https://ow.ly/LtnK50Yofyb
#JCLSpecialEdition #Obesity
A key characteristic of obesity is adipocytopathic atherogenic dyslipidemia. This review highlights the lipid specialist’s role in team-based obesity care to address cardiometabolic risk and improve long-term outcomes.
Read now: https://ow.ly/GOtQ50YmuEM
#JCLSpecialEdition #Obesity
Childhood obesity is a distinct condition with unique management needs. This review covers rising prevalence, genetic/environmental drivers, comorbidities & current treatments (IHBLT, metabolic surgery & pharmacotherapy).
Read now: https://ow.ly/AMmG50YlV5S
#JCLSpecialEdition #Obesity
Obesity management requires destigmatization and recognition as a chronic disease. This article highlights the role of GLP-1 RAs in achieving >10% weight loss with CV-kidney-metabolic benefits.
Read more: https://ow.ly/4QkW50Yl0Kv
NOW LIVE: #JCLSpecialEdition: Obesity as a Cardiometabolic Disease
How is obesity defined? This article evaluates the benefits and disadvantages of current and proposed measures to characterize obesity.
Read the review: https://ow.ly/xEBf50YkcVj
